Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors ; volume:11 ; number:1 ; day:4 ; month:7 ; year:2010 ; pages:1-14 ; date:12.2010
BMC medical genetics ; 11, Heft 1 (4.7.2010), 1-14, 12.2010
- Urheber
- Beteiligte Personen und Organisationen
-
Dietmaier, Wolfgang
Füzesi, Laszlo
Gaumann, Andreas
Haller, Florian
Kitz, Julia
Krohn, Antje
Mechtersheimer, Gunhild
Penzel, Roland
Schildhaus, Hans-Ulrich
Schneider-Stock, Regine
Simon, Ronald
Wardelmann, Eva
SpringerLink (Online service)
- DOI
-
10.1186/1471-2350-11-106
- URN
-
urn:nbn:de:1111-2016071511287
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Merkelbach-Bruse, Sabine
- Dietmaier, Wolfgang
- Füzesi, Laszlo
- Gaumann, Andreas
- Haller, Florian
- Kitz, Julia
- Krohn, Antje
- Mechtersheimer, Gunhild
- Penzel, Roland
- Schildhaus, Hans-Ulrich
- Schneider-Stock, Regine
- Simon, Ronald
- Wardelmann, Eva
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Advances in Small-Molecule C-KIT/PDGFRα Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors
Biochemische und strukturbiologische Charakterisierung der Rezeptortyrosinkinasen KIT und PDGFRA
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET
The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
Pretreatment Tumor DNA Sequencing of KIT and PDGFRA in Endosonography-Guided Biopsies Optimizes the Preoperative Management of Gastrointestinal Stromal Tumors
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Advances in Small-Molecule C-KIT/PDGFRα Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors
Biochemische und strukturbiologische Charakterisierung der Rezeptortyrosinkinasen KIT und PDGFRA
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET
The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
Pretreatment Tumor DNA Sequencing of KIT and PDGFRA in Endosonography-Guided Biopsies Optimizes the Preoperative Management of Gastrointestinal Stromal Tumors
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Advances in Small-Molecule C-KIT/PDGFRα Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors
Biochemische und strukturbiologische Charakterisierung der Rezeptortyrosinkinasen KIT und PDGFRA
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET
The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
Pretreatment Tumor DNA Sequencing of KIT and PDGFRA in Endosonography-Guided Biopsies Optimizes the Preoperative Management of Gastrointestinal Stromal Tumors